[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging
暂无分享,去创建一个
G. Loudos | E. Chiotellis | J. Reubi | B. Nock | T. Maina | A. Nikolopoulou | D. Maintas
[1] E. Spindel. Bombesin-like Peptides , 2003 .
[2] A. Beck‐Sickinger,et al. In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. , 2002, Nuclear medicine and biology.
[3] R. Schibli,et al. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. , 2002, Bioconjugate chemistry.
[4] J. Reubi,et al. Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[d-TYR6, β-ALA11, PHE13, NLE14] Bombesin(6–14) , 2002 .
[5] G. Loudos,et al. [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[6] J. Reubi,et al. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] T. Visser,et al. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives , 2001, European Journal of Nuclear Medicine.
[8] G. Slegers,et al. Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging? , 2001, Nuclear medicine communications.
[9] H. Friess,et al. Bombesin Receptors in Distinct Tissue Compartments of Human Pancreatic Diseases , 2000, Laboratory Investigation.
[10] G. Slegers,et al. Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study , 2000, European Journal of Nuclear Medicine.
[11] A. Schally,et al. Presence of receptors for bombesin/gastrin‐releasing peptide and mRNA for three receptor subtypes in human prostate cancers , 2000, The Prostate.
[12] J C Reubi,et al. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. , 1999, The American journal of pathology.
[13] A. Schally,et al. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. , 1999, European journal of endocrinology.
[14] T. Visser,et al. Evaluation of radiolabelled bombesin analogues for receptor‐targeted scintigraphy and radiotherapy , 1999, International journal of cancer.
[15] J C Reubi,et al. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. , 1999, Cancer research.
[16] H. Gali,et al. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent. , 1999, Bioconjugate chemistry.
[17] Antal Orosz,et al. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells , 1998, Journal of peptide science : an official publication of the European Peptide Society.
[18] H. Fuse,et al. Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. , 1998, Cancer letters.
[19] A. Schally,et al. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095. , 1998, European journal of cancer.
[20] P. Troncoso,et al. In situ hybridization for gastrin‐releasing peptide receptor (GRP receptor) expression in prostatic carcinoma , 1998, International journal of cancer.
[21] H. Wagner,et al. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. , 1998, Bioconjugate chemistry.
[22] A. Safavy,et al. Synthesis of bombesin analogues for radiolabeling with rhenium‐188 , 1997, Cancer.
[23] S. Chevalier,et al. Bombesin stimulates the motility of human prostate‐carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin‐associated proteins , 1997, International journal of cancer.
[24] M. Kane,et al. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. , 1996, Lung cancer.
[25] S. Chevalier,et al. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. , 1996, Journal of molecular endocrinology.
[26] A. Schally,et al. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. , 1995, Cancer research.
[27] 和田 恵津子. Mammalian bombesin receptors : cloning and in situ hybridization , 1995 .
[28] W. Travis,et al. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. , 1994, American journal of clinical pathology.
[29] A. Schally,et al. Characterization of high‐affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC‐3 and DU‐145: Internalization of receptor bound 125I‐(Tyr4) bombesin by tumor cells , 1994, The Prostate.
[30] A. Schally,et al. Effect of somatostatin analog RC‐160 and bombesin/gastrin releasing peptide antagonist RC‐3095 on growth of PC‐3 human prostate‐cancer xenografts in nude mice , 1993, International journal of cancer.
[31] R. Jensen,et al. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. , 1993, Molecular pharmacology.
[32] A. Schally,et al. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. , 1992, Cancer research.
[33] A. Gazdar,et al. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. , 1992, Cancer research.
[34] A. Schally,et al. Inhibition of growth of PC‐82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC‐3095 or combination of agonist [D‐Trp6]‐luteinizing hormone‐releasing hormone and somatostatin analog RC‐160 , 1992, The Prostate.
[35] R. Murphy,et al. Bombesin stimulates proliferation of human breast cancer cells in culture. , 1991, British Journal of Cancer.
[36] M. Papotti,et al. Expression of the gastrin‐releasing peptide gene in carcinomas of the breast , 1991, International journal of cancer.
[37] E. Rozengurt. Bombesin stimulation of mitogenesis. Specific receptors, signal transduction, and early events. , 1990, The American review of respiratory disease.
[38] R. Jensen,et al. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. , 1990, The Journal of biological chemistry.
[39] J. Abita,et al. Characterization, in some human breast cancer cell lines, of gastrin‐releasing peptide‐like receptors which are absent in normal breast epithelial cells , 1990, International journal of cancer.
[40] T. Moody,et al. Solubilization of the receptor for the neuropeptide gastrin-releasing peptide (bombesin) with functional ligand binding properties. , 1990, Biochemistry.
[41] M. Ciomei,et al. Bombesin stimulates growth of human prostatic cancer cells in vitro , 1990, Cancer.
[42] D. Parker,et al. Synthesis and Characterization of Stable Rhenium(V) Dioxo Complexes with Acyclic Tetraamine Ligands, (LReO2)+. , 1989 .
[43] V. Erspamer. Discovery, Isolation, and Characterization of Bombesin‐like Peptides , 1988 .
[44] P. McHugh,et al. Distribution of bombesin binding sites in the rat gastrointestinal tract , 1988, Peptides.
[45] D. Carney. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide , 1987, Regulatory Peptides.
[46] R. Bruzzone,et al. Bombesin effects on human GI functions , 1985, Peptides.
[47] John D. Minna,et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.
[48] E. Rozengurt,et al. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. Bruzzone,et al. Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man. , 1983, The Journal of clinical endocrinology and metabolism.
[50] M. Kastner,et al. Synthesis and structure of trans-[O2(en)2TcV]+ , 1982 .
[51] G Nilsson,et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. , 1979, Biochemical and biophysical research communications.
[52] C. Pert,et al. Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[53] V. Erspamer,et al. Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. , 1971, Experientia.